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Abstract
Background Liver failure following liver surgery is
caused by an insufﬁcient functioning remnant cell mass.
This can be due to insufﬁcient liver volume and can be
aggravated by additional cell death during or after surgery.
The aim of this study was to elucidate the causes of
hepatocellular injury in patients undergoing liver resection.
Methods Markers of hepatocyte injury (AST, GSTa, and
L-FABP) and inﬂammation (IL-6) were measured in
plasma of patients undergoing liver resection with and
without intermittent inﬂow occlusion. To study the separate
involvement of the intestines and the liver in systemic L-
FABP release, arteriovenous concentration differences for
L-FABP were measured.
Results During liver manipulation, liver injury markers
increased signiﬁcantly. Arterial plasma levels and
transhepatic and transintestinal concentration gradients of
L-FABP indicated that this increase was exclusively due to
hepatic and not due to intestinal release. Intermittent he-
patic inﬂow occlusion, anesthesia, and liver transection did
not further enhance arterial L-FABP and GSTa levels.
Hepatocyte injury was followed by an inﬂammatory re-
sponse.
Conclusions This study shows that liver manipulation is a
leading cause of hepatocyte injury during liver surgery. A
potential causal relation between liver manipulation and
systemic inﬂammation remains to be established; but since
the inﬂammatory response is apparently initiated early
during major abdominal surgery, interventions aimed at
reducing postoperative inﬂammation and related compli-
cations should be started early during surgery or before-
hand.
Liver failure is a severe complication of liver surgery,
occurring when there is insufﬁcient remnant cell mass
postoperatively. This can be due to excessive resection,
leaving a too small remnant liver volume, but in some
cases liver failure occurs in patients with a seemingly
sufﬁcient remnant liver volume [1]. In these cases the
functional capacity of the remaining cell mass is probably
impaired by secondary processes. Recognition and modu-
lation of factors impairing cell survival is crucial to en-
hance liver function following liver surgery. In this context
much attention has been paid to the effects of ischemia and
reperfusion.
Ischemia-reperfusion is a frequently encountered phe-
nomenon in liver resection, caused by temporary occlu-
sion of blood ﬂow to the liver (Pringle maneuver), which
is a popular way to reduce blood loss during parenchymal
liver transection. Ischemia-reperfusion induces energy
depletion and generation of reactive oxygen species. Al-
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at supporting cell survival are activated during ischemia-
reperfusion [2], excessive energy depletion or oxidative
stress ultimately results in apoptotic or necrotic cell death.
Interestingly, it has been shown that plasma levels of
markers for hepatocellular injury increase before liver
transection and before application of the Pringle maneuver,
suggesting that factors other than ischemia-reperfusion
may cause hepatocyte demise during liver surgery [3]. In
this context a role has been proposed for the hepatotoxic
effects of anesthesia [4], the effects of systemic inﬂam-
mation, probably secondary to intestinal manipulation [5],
and the effects of manipulation of the liver itself during
perihepatic dissection and mobilization [6]. The aim of this
study was to elucidate the causes of early hepatocellular
injury in patients undergoing liver resection.
Methods
Patients
Patients undergoing liver resection for secondary tumors in
an otherwise healthy liver were studied (Table 1). All pa-
tients were anesthetized according to institutional routines
using isoﬂurane and propofol. Surgery was commenced
using a subcostal bilateral incision. Olivier retractors
(Copharm, Abcoude, Holland) or Omni-Tracts were used
to improve exposure. Before parenchymal division the liver
was mobilized as described elsewhere, followed by intra-
operative ultrasound [7]. Cholecystectomy was performed
routinely before liver transection. All patients had
indwelling radial artery catheters placed for continuous
monitoring of arterial blood pressure and blood sampling.
Patients were nonrandomly assigned to one of two proto-
cols (described below). Assignment was based upon the
surgeon’s preference of using the Pringle maneuver or not.
If applied, an intermittent Pringle maneuver (15 min of
ischemia, 5 min of reperfusion) was used by rubberband
ligation of the hepatoduodenal ligament.
Effects of intermittent Pringle maneuver on
hepatocellular injury
From nine patients undergoing liver resection with inter-
mittent Pringle maneuver, arterial blood was sampled
preoperatively before and after each period of 15 min of
ischemia and 5 min of reperfusion and 90 minutes post-
operatively. Systemic concentrations of two markers of
hepatocellular injury, aspartate amino transferase (AST)
and glutathione-s-transferase-a (GSTa), were measured as
well as plasma levels of liver-type fatty acid binding pro-
tein (L-FABP). Methods of blood processing and labora-
tory analyses are described below. In addition, plasma
levels of the inﬂammatory cytokine interleukin-6 (IL-6)
were measured as described below.
Source and fate of L-FABP
From ten patients undergoing liver resection without the
Pringle maneuver, arterial blood was sampled preopera-
tively and before liver transection. Simultaneous with the
second arterial blood sample, blood was drawn from the
portal vein, a hepatic vein, and the right renal vein by
direct puncture to assess concentration gradients across
organs. It should be noted that at this timepoint surgical
procedures were identical in all patients, irrespective of
the eventual application of a Pringle maneuver. L-FABP
plasma concentrations were measured as described below
and arteriovenous concentration differences were calcu-
lated to study the contribution of the intestines and the
liver to systemic L-FABP release and to study
renal clearance of L-FABP. Renal clearance was calcu-
lated by dividing the arteriovenous concentration gradient
by the arterial concentration (uptake/inﬂux). This
quotient was multiplied by the percentage of blood
ﬂowing through the kidney to calculate fractional plasma
clearance.
Effects of anesthesia and intestinal manipulation
To differentiate the effects of anesthesia induction, lapa-
rotomy, and intestinal manipulation from the effects of li-
ver manipulation, a control group consisting of four
patients undergoing lower abdominal surgery (1 rectopex-
ia, 2 proctectomy, 1 sigmoidal resection) was studied.
Plasma was sampled before surgery and at 40-min intervals
during surgery to determine L-FABP concentrations.
Table 1 Patient characteristics
Hepatectomy
w/o IPM (n = 11)
Hepatectomy
with IPM (n =9 )
Age (yr) 57 (36–72) 54 (33–75)
Male:Female 9:2 5:4
AST (IU/L) 26 (13–40) 23 (7–37)
LDH (IU/L) 337 (1–558) 377 (295–490)
Albumin (g/L) 39.0 (33.9–43.9) 37.6 (33.7–43.9)
CRP (mg/L) 3.5 (<1.0–8.7) 5.0 (<1.0–8.7)
Bilirubin (lmol/L) 13.4 (7.7–18.7) 12.9 (8.4–21)
IPM = intermittent Pringle maneuver
Blood chemistry was obtained during routine assessment one day
preoperatively. Values are expressed as median (range).
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Blood samples were collected in prechilled EDTA vacuum
tubes (BD vacutainer, Becton Dickinson Diagnostics,
Aalst, Belgium) and kept on ice. Blood was centrifuged at
4000g for 10 min. Plasma was immediately stored at -80 C
until analysis. L-FABP and IL-6 were determined using
commercially available enzyme-linked immunosorbent
assays (ELISA) (kindly provided by Hycult Biotechnology,
Uden, The Netherlands), GSTa was measured by ELISA as
described earlier [8, 9]. AST was determined by the clinical
chemistry laboratory of the University Hospital Maastricht.
Ethics
The studies were approved by the Medical Ethics Com-
mittee of the University Hospital Maastricht and all sub-
jects gave written informed consent.
Statistics
Normality of all data obtained was veriﬁed by Lillieford’s
test (all p > 0.10). Data are presented as mean with standard
error of the mean (SEM). A paired t test was used to test
the signiﬁcance of changes in the various plasma concen-
trations. Arteriovenous concentration gradients were tested
versus a theoretical mean of zero using a one-sample t test
[10]. Pearson’s test for correlations was used to test the
signiﬁcance of correlations. Statistical calculations were
made using Prism 4.0 for Windows (GraphPad Software
Inc., San Diego, CA). A p value less than 0.05 was con-
sidered to indicate statistical signiﬁcance.
Results
Patient outcome
No signs of organ failure or other major complications
were observed postoperatively during the hospital stay of
all patients.
Estimation of hepatocellular injury and intestinal injury
after organ manipulation
Systemic levels of damage markers
During assessment of resectability, prior to organ transec-
tion, mean arterial L-FABP plasma concentration increased
55-fold (p = 0.002) (Fig. 1a). Surprisingly, arterial L-FABP
levels did not change signiﬁcantly during subsequent
intermittent Pringle maneuver, indicating that neither
intermittent ischemia-reperfusion nor liver transection
signiﬁcantly aggravated the hepatocellular injury caused by
early perioperative processes. Immediately postoperatively,
systemic L-FABP levels were found to be decreasing.
Fig. 1 Mean (SEM) arterial L-FABP (a), GSTa (b), and AST (c)
levels in patients undergoing liver surgery with intermittent Pringle
maneuver (n = 9). Plasma levels of all liver injury markers increased
early during surgery, during liver manipulation (p < 0.05). Intermittent
Pringle maneuver (2 · 15 min ischemia and 5 min reperfusion) did not
cause signiﬁcant changes in arterial L-FABP or GSTa levels, whereas
AST gradually kept increasing. L-FABP and GSTa levels decreased
immediately postoperatively (p = 0.03 and p = 0.004, respectively).
*p
< 0.05, ns = not signiﬁcant; I = ischemia, R = reperfusion
World J Surg (2007) 31:2033–2038 2035
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(Fig. 1c) also increased signiﬁcantly before liver transec-
tion and before ischemia-reperfusion.
Effects of lower abdominal surgery on liver injury
Inpatientsundergoinglowerabdominalsurgery,themeanL-
FABP concentration remained below 15 ng/ml, underlining
the effect of direct manipulation of the liver on the elevation
of L-FABP plasma levels during liver surgery (Fig. 2).
Organ-speciﬁc FABP release
Since L-FABP is expressed in both the liver and the intes-
tines, we performed an organ balance analysis to reveal the
origin of circulating L-FABP. The data show that L-FABP
was speciﬁcally released from the liver and not from the
intestines. In addition, organ balance analysis showed an
active renal uptake of L-FABP from circulation (Fig. 3).
Renal clearance of FABPs
The kidneys efﬁciently removed L-FABP from circulation.
Renal clearance of L-FABP correlated directly with their
respective arterial concentrations (Fig. 4), resulting in a
fractional extraction rate (arteriovenous gradient/arterial
concentration · 100%) [11] of approximately 30%.
Assuming that renal blood ﬂow per minute approximates
22% of the total blood volume [12], renal plasma L-FABP
clearance can be calculated to equal 6.6%/min (30% ·
22%/min), resulting in a plasma half-life of about 11 min.
Interleukin-6 levels during liver surgery with
intermittent Pringle maneuver
The inﬂammatory response to liver surgery was investi-
gated using IL-6 as a parameter. Arterial IL-6 levels
remained unaltered during manipulation of the liver, when
L-FABP, AST, and GSTa levels were increasing. In con-
trast, a signiﬁcant increase of systemic IL-6 plasma levels
was found after 15 min of hepatic inﬂow occlusion
(Fig. 5). This increase was progressive throughout the
remainder of the study period.
Discussion
The present study was designed to determine the cause of
early hepatocellular injury during liver resection. Previous
publications already showed elevated plasma levels of
markers of liver damage prior to liver transection and he-
patic inﬂow occlusion [3, 6]. These observations suggested
that mechanisms other than ischemia-reperfusion injury
could contribute to peri- and postoperative cell death and
Fig. 2 Mean (SEM) plasma L-FABP levels in four patients
undergoing lower abdominal surgery without manipulation of the
liver. No changes in L-FABP concentration were observed
Fig. 3 Mean (SEM) arteriovenous concentration gradients of L-
FABP across the intestines (portal vein minus artery), the liver
(hepatic vein minus portal vein), and the kidney in patients
undergoing liver resection (n = 10). L-FABP was speciﬁcally released
from the liver (p < 0.0001 vs. zero) and removed from circulation by
the kidneys (p < 0.0001 vs. zero)
Fig. 4 Fractional renal clearance of L-FABP in patients undergoing
liver resection (n = 10). From the fractional renal extraction of FABPs
(approximately 30%) and renal blood ﬂow (22% of total blood
volume per minute) [12], a plasma half-life of FABPs of 11 min can
be calculated. [A] = arterial concentration, [RV] = renal venous
concentration
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123organ dysfunction. We showed that direct manipulation of
the liver during surgery is a leading cause of hepatocellular
injury.
Arterial L-FABP and GSTa plasma levels increased
following the start of the operation and reached a plateau
before liver transection and ischemia-reperfusion. Sur-
prisingly, we found no additional effect of organ transec-
tion or intermittent Pringle maneuver on these increased L-
FABP and GSTa plasma levels. The apparent resistance of
the liver to an ischemic insult however, is in line with
previous data by Figueras et al. [13] who showed no effect
of the extent of inﬂow occlusion in patients with a normal
liver, although in their study livers of patients with cir-
rhosis appeared to be more vulnerable to hepatic inﬂow
occlusion. In addition, other authors who showed a pro-
gressive release of GSTa following a Pringle maneuver
applied prolonged and continuous inﬂow occlusion [6],
which is known to aggravate hepatocellular injury com-
pared to the intermittent Pringle maneuver [14].
Previous authors who observed an early increase in
plasma concentrations of transaminases and GSTa have
ascribed this phenomenon to the hepatotoxic effects of
anesthesia [4], systemic inﬂammation after intestinal
manipulation [5], and the effects of manipulation of the
liver itself during perihepatic dissection and mobilization
[6]. We were able to rule out the ﬁrst two factors as po-
tential causes of early hepatocyte injury since a similar
increase of L-FABP plasma concentrations did not occur in
patients undergoing lower intestinal surgery. These patients
were anesthetized in a similar manner as the patients
undergoing liver resection and underwent extensive intes-
tinal manipulation.
By elimination of other potential causes, it thus must be
concluded that increasing L-FABP levels occurs during and
due to liver manipulation in patients undergoing liver
resection. By measuring concentration gradients across the
intestines and the liver, we were able to show that the
increased L-FABP levels during liver manipulation are
exclusively due to L-FABP release from the liver. Some
intestinal L-FABP release could have been expected when
L-FABP, which is also expressed by the intestines, would
have been released from injured enterocytes, but the ab-
sence of intestinal L-FABP release clearly indicates that
organ manipulation during liver resection results in hepa-
tocellular injury without causing intestinal injury.
Finally, we were able to rule out systemic inﬂammation
as a leading cause of hepatocellular injury since L-FABP
peak levels were reached already before the onset of the
inﬂammatory response. Arterial IL-6 plasma levels in-
creased between 90 and 125 min after laparotomy, which
approximates the established time lag between an inﬂam-
matory stimulus and IL-6 release [15]. This suggests that
the inﬂammatory response is triggered by an early event
during the operation.
According to the ‘‘danger model’’ hypothesis of Matz-
inger [16], cell injury leads to the release of immuno-
stimulatory proteins or nucleotides, so-called danger
signals, that activate the immune system and induce sys-
temic inﬂammation [17]. In line with this theory, we con-
sider that early hepatocyte damage due to liver
manipulation could give rise to the release of such ‘‘danger
signals’’ and contribute to systemic inﬂammation. Conse-
quently, liver manipulation-induced hepatocyte injury may
be a trigger for the inﬂammatory response to surgery.
Mechanistic proof for this theory, however, is difﬁcult to
obtain in vivo.
Both L-FABP and GSTa decreased immediately fol-
lowing surgery, in contrast to the more classic marker of
hepatocyte injury, AST. The ongoing increase of plasma
levels of such markers following liver surgery has been
regarded as a sign of ongoing hepatocellular injury and
impending liver failure [18]. Our study shows that the late
postoperative peak of AST is more likely to be a reﬂection
of slow leakage than of ongoing injury, since the leakage of
small-molecular proteins L-FABP and GSTa decreased
within 90 min. As a consequence, L-FABP and GSTa are
probably more sensitive for detecting ongoing hepatocyte
injury and impending liver failure than AST. To prove this
assumption, however, a large prospective study is needed.
The rapid decline of L-FABP and GSTa is a result of their
rapid renal clearance. Arterial renal venous concentration
gradients showed that the kidneys remove approximately
30% of L-FABP in a single pass, leading to a calculated L-
FABP half-life of 11 min.
We did not explore potential mechanisms of liver
manipulation-induced cell injury. Earlier studies showed
that liver mobilization and assessment of resectability
signiﬁcantly reduced hepatic venous oxygen saturation [19,
Fig. 5 Mean (SEM) arterial IL-6 concentration before, during, and
after liver resection with intermittent Pringle maneuver (n = 9). * =
ﬁrst timepoint where p < 0.05 vs. baseline; I = ischemia, R =
reperfusion
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case, although we did not measure hepatic oxygen satura-
tion. It is not clear whether hepatic oxygen saturation de-
creased due to physical obstruction of the blood stream or
whether it decreased secondary to other processes [21, 22].
Alternatively, cell damage may occur as a direct conse-
quence of mechanical impact [23].
In summary, it was previously believed that vascular
occlusion and parenchymal transection were the major
reasons for hepatocyte injury during liver surgery. This
study demonstrates that liver manipulation is a leading
cause of hepatocyte injury during liver surgery. A potential
causal relation between liver manipulation and systemic
inﬂammation remains to be established. However, since the
inﬂammatory cascade is apparently initiated early during
major abdominal surgery, interventions aimed at reducing
postoperative inﬂammation and related complications
should be started early during surgery or beforehand.
Acknowledgments The authors thank M. Hadfoune and A.A. van
Bijnen for their skillful help in our laboratory. This study was sup-
ported by grants from The Netherlands Organization for Health Re-
search and Development to MCGvdP (920-03-317 AGIKO) and
CHCD (907-00-033 Clinical Fellowship).
References
1. Wigmore SJ, Redhead DN, Yan XJ, et al. (2001) Virtual hepatic
resection using three-dimensional reconstruction of helical com-
puted tomography angioportograms. Ann Surg 233:221–226
2. Patel A, van de Poll MC, Greve JW, et al. (2004) Early stress
protein gene expression in a human model of ischemic precon-
ditioning. Transplantation 78:1479–1487
3. Boschetto A, Dondero F, Tonini V, et al. (2005) Intra-operative
liver injury is not only related to vascular clamping [abstract].
HPB 7:P25
4. Clarke RS, Doggart JR, Lavery T (1976) Changes in liver func-
tion after different types of surgery. Br J Anaesth 48:119–128
5. Hiki N, Shimizu N, Yamaguchi H, et al. (2006) Manipulation of
the small intestine as a cause of the increased inﬂammatory re-
sponse after open compared with laparoscopic surgery. Br J Surg
93:195–204
6. Chouker A, Martignoni A, Schauer RJ, et al. (2005) a-Glutha-
thione s-transferase as an early marker of hepatic ischemia/rep-
erfusion injury after liver resection. World J Surg 29:528–534
7. Dejong CHC, Garden OJ (2003) Neoplasms of the liver. In:
Majid AA, Kingsnorth A (eds) Advanced surgical practice.
London, Greenwich Medical Media, pp 146–156
8. Mulder TP, Peters WH, Court DA, et al. (1996) Sandwich ELISA
for glutathione S-transferase alpha 1-1: plasma concentrations in
controls and in patients with gastrointestinal disorders. Clin
Chem 42:416–419
9. Steegers EA, Mulder TP, Bisseling JG, et al. (1995) Glutathione
S-transferase alpha as marker for hepatocellular damage in pre-
eclampsia and HELLP syndrome. Lancet 345:1571–1572
10. Motulsky HJ (2003) Comparing a mean or median to a theoretical
value. Prism 4 Statistics Guide: Statistical analyses for laboratory
and clinical researchers. GraphPad Software Inc., San Diego, CA,
pp 35–39
11. van de Poll MC, Siroen MP, van Leeuwen PA, et al. (2007)
Interorgan amino acid exchange in humans: consequences for
arginine and citrulline metabolism. Am J Clin Nutr 85:167–172
12. Riddez L, Hahn RG, Brismar B, et al. (1997) Central and regional
hemodynamics during acute hypovolemia and volume substitu-
tion in volunteers. Crit Care Med 25:635–640
13. Figueras J, Llado L, Ruiz D, et al. (2005) Complete versus
selective portal triad clamping for minor liver resections: a pro-
spective randomized trial. Ann Surg 241:582–590
14. Belghiti J, Noun R, Malafosse R, et al. (1999) Continuous versus
intermittent portal triad clamping for liver resection: a controlled
study. Ann Surg 229:369–375
15. Lin E, Calvano SE, Lowry SF (2000) Inﬂammatory cytokines and
cell response in surgery. Surgery 127:117–126
16. Matzinger P (2002) The danger model: a renewed sense of self.
Science 296:301–305
17. Barrat FJ, Meeker T, Gregorio J, et al. (2005) Nucleic acids of
mammalian origin can act as endogenous ligands for Toll-like
receptors and may promote systemic lupus erythematosus. J Exp
Med 202:1131–1139
18. Panis Y, McMullan DM, Emond JC (1997) Progressive necrosis
after hepatectomy and the pathophysiology of liver failure after
massive resection. Surgery 121:142–149
19. Kretzschmar M, Kruger A, Schirrmeister W (2003) Hepatic
ischemia-reperfusion syndrome after partial liver resection (LR):
hepatic venous oxygen saturation, enzyme pattern, reduced and
oxidized glutathione, procalcitonin and interleukin-6. Exp Toxi-
col Pathol 54:423–431
20. Kainuma M, Fujiwara Y, Kimura N, et al. (1991) Monitoring
hepatic venous hemoglobin oxygen saturation in patients under-
going liver surgery. Anesthesiology 74:49–52
21. Schemmer P, Enomoto N, Bradford BU, et al. (2001) Activated
Kupffer cells cause a hypermetabolic state after gentle in situ
manipulation of liver in rats. Am J Physiol Gastrointest Liver
Physiol 280:G1076–1082
22. Schemmer P, Enomoto N, Bradford BU, et al. (2001) Autonomic
nervous system and gut-derived endotoxin: involvement in acti-
vation of Kupffer cells after in situ organ manipulation. World J
Surg 25:399–406
23. Lazarowski ER, Homolya L, Boucher RC, et al. (1997) Direct
demonstration of mechanically induced release of cellular UTP
and its implication for uridine nucleotide receptor activation. J
Biol Chem 272:24348–24354
2038 World J Surg (2007) 31:2033–2038
123